What is it about?

Co-inhalation of roflumilast+fluticasone more significantly improved asthma than co-inhalation of formoterol+fluticasone in mice. Further studies are needed to help confirm the potential off-label add-on use of roflumilast in typical and atypical asthma and Asthma-COPD Overlap Syndrome

Featured Image

Read the Original

This page is a summary of: Co-inhalation of roflumilast, rather than formoterol, with fluticasone more effectively improves asthma in asthmatic mice, Experimental Biology and Medicine, March 2017, SAGE Publications,
DOI: 10.1177/1535370216685006.
You can read the full text:

Read

Contributors

The following have contributed to this page